EUVIMEDEUVIMED entdecken
Crossref

Unveiling the potential of intralesional acyclovir in managing cutaneous warts

Pooja Dilip Shah, Bela Bhemabhai Padhiar, T. S. Sreelakshmi

Journal of Cutaneous and Aesthetic Surgery · 06.07.2026 · 1-6

DOI: 10.25259/jcas_205_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous and Aesthetic Surgery, online erschienen am 06.07.2026. Verfasst von Pooja Dilip Shah und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Managing cutaneous warts caused by human papillomavirus (HPV) remains challenging, with existing treatments often limited by high recurrence and variable efficacy. Given the viral origin of warts and the proven efficacy of acyclovir against DNA viruses, it may offer a novel therapeutic approach for targeting HPV. This study aimed to evaluate the efficacy and safety of intralesional acyclovir in the management of cutaneous warts. Material and Methods: After institutional ethics committee approval, a single-arm prospective interventional study was conducted at a tertiary care hospital. After recording demographic and clinical history, patients were treated with intralesional acyclovir (70 mg/mL) every 2 weeks until wart clearance or a maximum of five sessions. Clinical photographs were taken at each visit to assess treatment response, and side effects were recorded. Data were analyzed using appropriate statistical tests.

Results

Out of the 45 patients who completed the study, complete wart clearance was achieved in 73.33% ( n = 33), while partial and no response were observed in 22.22% ( n = 10) and 4.44% ( n = 2), respectively. The highest clearance rate was seen in plantar warts (84.62%), followed by 77.78% in palmar warts and 40% in common warts, with periungual warts showing partial resolution. Side effects were reported in 66.67% ( n = 30), with hemorrhagic eschar (56.67%, n = 17) and blister formation (43.33%, n = 13) being the most common.

Conclusion

Intralesional acyclovir, with its potential to directly target HPV, represents a promising, safe, and effective new approach in the armamentarium for the treatment of warts.

Zitieren

APA

Shah, P. D., Padhiar, B. B., & Sreelakshmi, T. S. (2026). Unveiling the potential of intralesional acyclovir in managing cutaneous warts. Journal of Cutaneous and Aesthetic Surgery, 0, 1-6. https://doi.org/10.25259/jcas_205_2025

Vancouver

Shah PD, Padhiar BB, Sreelakshmi TS. Unveiling the potential of intralesional acyclovir in managing cutaneous warts. Journal of Cutaneous and Aesthetic Surgery. 2026;0:1-6. doi:10.25259/jcas_205_2025

BibTeX
@article{Shah2026,
  author = {Shah, Pooja Dilip and Padhiar, Bela Bhemabhai and Sreelakshmi, T. S.},
  title = {Unveiling the potential of intralesional acyclovir in managing cutaneous warts},
  journal = {Journal of Cutaneous and Aesthetic Surgery},
  year = {2026},
  volume = {0},
  pages = {1--6},
  doi = {10.25259/jcas_205_2025}
}
Kostenlos starten →